These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38591056)

  • 1. HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy-an
    Tubertini M; Menilli L; Milani C; Martini C; Navacchia ML; Nugnes M; Bartolini M; Naldi M; Tedesco D; Martella E; Guerrini A; Ferroni C; Moret F; Varchi G
    Front Chem; 2024 Mar; 12():1378233. PubMed ID: 38591056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corrigendum: HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy-an
    Tubertini M; Menilli L; Milani C; Martini C; Navacchia ML; Nugnes M; Bartolini M; Naldi M; Tedesco D; Martella E; Guerrini A; Ferroni C; Moret F; Varchi G
    Front Chem; 2024; 12():1443822. PubMed ID: 38957407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy.
    Sun J; Wan Z; Chen Y; Xu J; Luo Z; Parise RA; Diao D; Ren P; Beumer JH; Lu B; Li S
    Acta Biomater; 2020 Apr; 106():289-300. PubMed ID: 32004652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel prodrug and its nanoformulation suppress cancer stem cells by inducing immunogenic cell death and inhibiting indoleamine 2, 3-dioxygenase.
    Guan J; Wu Y; Liu X; Wang H; Ye N; Li Z; Xiao C; Zhang Z; Li Z; Yang X
    Biomaterials; 2021 Dec; 279():121180. PubMed ID: 34768152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression.
    Kim M; Lee JS; Kim W; Lee JH; Jun BH; Kim KS; Kim DE
    J Control Release; 2022 Aug; 348():893-910. PubMed ID: 35760233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockage of the IDO1 pathway by charge-switchable nanoparticles amplifies immunogenic cell death for enhanced cancer immunotherapy.
    Shi M; Zhang J; Wang Y; Han Y; Zhao X; Hu H; Qiao M; Chen D
    Acta Biomater; 2022 Sep; 150():353-366. PubMed ID: 35843594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification.
    Huai M; Wang Y; Li J; Pan J; Sun F; Zhang F; Zhang Y; Xu L
    J Nanobiotechnology; 2024 May; 22(1):257. PubMed ID: 38755645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Mechanism of a Biomimetic Nanosystem Carrying Doxorubicin and an IDO Inhibitor for Treatment of Advanced Triple-Negative Breast Cancer.
    Hu C; Liu Y; Cao W; Li N; Gao S; Wang Z; Gu F
    Int J Nanomedicine; 2024; 19():507-526. PubMed ID: 38260240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Dual-Targeting Liposome Enhances Triple-Negative Breast Cancer Chemoimmunotherapy through Inducing Immunogenic Cell Death and Inhibiting STAT3 Activation.
    Luo K; Yang L; Yan C; Zhao Y; Li Q; Liu X; Xie L; Sun Q; Li X
    Small; 2023 Oct; 19(40):e2302834. PubMed ID: 37264710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential use of lapatinib-loaded human serum albumin nanoparticles in the treatment of triple-negative breast cancer.
    Wan X; Zheng X; Pang X; Zhang Z; Jing T; Xu W; Zhang Q
    Int J Pharm; 2015 Apr; 484(1-2):16-28. PubMed ID: 25700543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin-/NLG919 prodrugs-constructed liposomes for effective chemo-immunotherapy of colorectal cancer.
    Shen F; Feng L; Zhu Y; Tao D; Xu J; Peng R; Liu Z
    Biomaterials; 2020 Oct; 255():120190. PubMed ID: 32563943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy.
    Ma X; Yang S; Zhang T; Wang S; Yang Q; Xiao Y; Shi X; Xue P; Kang Y; Liu G; Sun ZJ; Xu Z
    Acta Pharm Sin B; 2022 Jan; 12(1):451-466. PubMed ID: 35127398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual functional immunostimulatory polymeric prodrug carrier with pendent indoximod for enhanced cancer immunochemotherapy.
    Wan Z; Sun J; Xu J; Moharil P; Chen J; Xu J; Zhu J; Li J; Huang Y; Xu P; Ma X; Xie W; Lu B; Li S
    Acta Biomater; 2019 May; 90():300-313. PubMed ID: 30930305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model.
    Mediratta K; El-Sahli S; Marotel M; Awan MZ; Kirkby M; Salkini A; Kurdieh R; Abdisalam S; Shrestha A; Di Censo C; Sulaiman A; McGarry S; Lavoie JR; Liu Z; Lee SH; Li X; Sciumè G; D'Costa VM; Ardolino M; Wang L
    Front Immunol; 2024; 15():1366197. PubMed ID: 38601156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomimetic Human Serum Albumin Nanoparticle for Efficiently Targeting Therapy to Metastatic Breast Cancers.
    Liu L; Bi Y; Zhou M; Chen X; He X; Zhang Y; Sun T; Ruan C; Chen Q; Wang H; Jiang C
    ACS Appl Mater Interfaces; 2017 Mar; 9(8):7424-7435. PubMed ID: 28150932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy.
    Huang Z; Chen Y; Zhang J; Li W; Shi M; Qiao M; Zhao X; Hu H; Chen D
    ACS Appl Mater Interfaces; 2021 Aug; 13(33):39934-39948. PubMed ID: 34396771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CaCO
    Zhu Y; Yang Z; Dong Z; Gong Y; Hao Y; Tian L; Yang X; Liu Z; Feng L
    Nanomicro Lett; 2020 Nov; 13(1):29. PubMed ID: 34138248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Indoleamine 2,3-Dioxygenase Enhances the Therapeutic Efficacy of Immunogenic Chemotherapeutics in Breast Cancer.
    Gao J; Deng F; Jia W
    J Breast Cancer; 2019 Jun; 22(2):196-209. PubMed ID: 31281723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tandem Chemoimmunotherapy by a Cascade-Responsive Molecular Prodrug.
    Yang Z; Luo X; Lin Y; Huang J; Lin H; Gao J
    ACS Chem Biol; 2022 Apr; 17(4):762-767. PubMed ID: 35285234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination of a TLR7/8 agonist and an epigenetic inhibitor suppresses triple-negative breast cancer through triggering anti-tumor immune.
    Jiang Z; Cai G; Liu H; Liu L; Huang R; Nie X; Gui R; Li J; Ma J; Cao K; Luo Y
    J Nanobiotechnology; 2024 May; 22(1):296. PubMed ID: 38811964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.